KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Profit After Tax (2016 - 2025)

Teladoc Health (TDOC) has disclosed Profit After Tax for 12 consecutive years, with -$25.1 million as the latest value for Q4 2025.

  • Quarterly Profit After Tax rose 48.06% to -$25.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$200.3 million through Dec 2025, up 79.99% year-over-year, with the annual reading at -$200.3 million for FY2025, 79.99% up from the prior year.
  • Profit After Tax hit -$25.1 million in Q4 2025 for Teladoc Health, up from -$49.5 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$11.0 million in Q4 2021 to a low of -$6.7 billion in Q1 2022.
  • Historically, Profit After Tax has averaged -$775.5 million across 5 years, with a median of -$71.4 million in 2022.
  • Biggest five-year swings in Profit After Tax: tumbled 34584.31% in 2022 and later soared 99.24% in 2023.
  • Year by year, Profit After Tax stood at -$11.0 million in 2021, then crashed by 34584.31% to -$3.8 billion in 2022, then skyrocketed by 99.24% to -$28.9 million in 2023, then tumbled by 67.56% to -$48.4 million in 2024, then surged by 48.06% to -$25.1 million in 2025.
  • Business Quant data shows Profit After Tax for TDOC at -$25.1 million in Q4 2025, -$49.5 million in Q3 2025, and -$32.7 million in Q2 2025.